Revelation Biosciences Warrant
REVBW
14 hedge funds and large institutions have $25.9K invested in Revelation Biosciences Warrant in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
61.41% more ownership
Funds ownership: 21.52% → 82.93% (+61%)
17% more funds holding
Funds holding: 12 → 14 (+2)
28% less capital invested
Capital invested by funds: $36.1K → $25.9K (-$10.1K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$238 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$77 |
| 3 |
CS
Clear Street
New York
|
+$3 |
| 4 |
CAC
Cowen and Company
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
-$530 |
| 2 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
-$47 |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $5.8K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $4.94K | – | – | – |
|
3
Walleye Capital
New York
| $3.74K | – | – | – |
|
|
PVI
4
Pine Valley Investments
Marlton,
New Jersey
| $2.84K | -$47 | -2,858 | -2% |
|
5
Walleye Trading
New York
| $2.1K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $2K | +$2 | +100 | +0.1% |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $1.44K | – | – | – |
|
8
Jane Street
New York
| $1K | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| $917 | -$11 | -674 | -1% |
|
|
PFM
10
Privium Fund Management
Amsterdam,
Netherlands
| $752 | – | – | – |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $292 | +$238 | +14,575 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| $94 | +$77 | +4,715 | New |
|
|
PIS
13
POM Investment Strategies
Raleigh,
North Carolina
| $20 | – | – | – |
|
|
CS
14
Clear Street
New York
| $4 | +$3 | +200 | New |
|
|
EPM
15
Equitec Proprietary Markets
Chicago,
Illinois
| – | -$530 | -20,000 | Closed |
|
REVBW Hedge Fund Activity: Q2 2024 in Review
14 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2024, worth a combined $25.9K — down 28% from $36.1K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVBW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $238. The largest seller was Equitec Proprietary Markets, exiting entirely with an estimated $530 sold.
- 14 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2024, up from 12 in Q1 2024.
- Funds reported $25.9K of Revelation Biosciences Warrant stock for Q2 2024, down 28% quarter-over-quarter.
- 3 funds opened new Revelation Biosciences Warrant positions in Q2 2024 and 1 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q2 2024 was Susquehanna International Group, an estimated $238 added.
- The largest Revelation Biosciences Warrant seller in Q2 2024 was Equitec Proprietary Markets, an estimated $530 sold.
Based on aggregated 13F filings for Q2 2024.